Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195867 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-07-20 | 2023-10-04 | 199313 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2023-11-03 | 2023-12-14 | 209116 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Actual shortage | 2024-01-11 | 2024-03-28 | 215704 |
| TEVA-TOPILENE | 0.05% | CREAM | Actual shortage | 2024-02-08 | 2024-02-08 | 218949 |
| TEVA-TOPILENE | 0.05% | CREAM | Actual shortage | 2024-02-29 | 2024-04-11 | 220989 |
| TEVA-TOPISONE | 0.05% | CREAM | Actual shortage | 2024-02-29 | 2024-05-03 | 220992 |
| TEVA-NYSTATIN | 100000UNIT | DROPS | Resolved | 2017-03-14 | 2018-03-08 | 2410 |
| PEDIATRIX DROPS | 80MG | DROPS | Resolved | 2022-09-07 | 2023-06-09 | 168719 |
| TEVA-PROPOFOL | 10MG | EMULSION | Actual shortage | 2020-04-10 | 2020-05-14 | 111871 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2020-04-23 | 2020-05-21 | 113028 |
| TEVA-PROPOFOL | 10MG | EMULSION | Actual shortage | 2020-07-30 | 2020-07-30 | 121494 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-01-07 | 2021-02-05 | 131066 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-07-22 | 2021-09-30 | 142902 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-01-27 | 2022-02-25 | 153742 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-03-10 | 2022-05-19 | 156410 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2022-12-01 | 2022-12-15 | 176788 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-02-16 | 2023-08-04 | 184931 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-06-19 | 2023-07-05 | 195563 |
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2023-11-16 | 2023-11-23 | 210431 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |